Symphony Limited - 517385 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of One-on-one meeting / video call with Institutional Investor(s).09-11-2022
09-11-2022
Symphony Limited - 517385 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of One-on-one meeting / video call with Institutional Investor(s).07-11-2022
Symphony Limited - 517385 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate(s).02-11-2022
Symphony Limited - 517385 - Announcement under Regulation 30 (LODR)-Investor Presentation
Corporate Presentation01-11-2022
Symphony Limited - 517385 - Intimation For Revision In Fair Disclosure Code.
Intimation for Revision in Fair Disclosure Code.31-10-2022
Symphony Limited - 517385 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings conference call of Q2FY2327-10-2022
Buy Symphony; target of Rs 1223: YES Securities
YES Securities is bullish on Symphony has recommended buy rating on the stock with a target price of Rs 1223 in its research report dated October 20, 2022.24-10-2022
Symphony Limited - 517385 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper clippings of publication of financial results21-10-2022
Symphony Limited - 517385 - Disclosure Of Related Party Transaction For The Half Year Ended September 30, 2022
Disclosure of Related Party Transaction for the half year ended September 30, 202221-10-2022
US DFC, others back Soothe Healthcare in bridge round
The company raised 120 crore in equity from A91 Partners, Symphony International Holdings Ltd, Sixth Sense Ventures and Gulf Islamic Investments while US DFC invested 55 crore in debt.21-10-2022